首页> 外国专利> Peptide inhibiting rankl-rank interaction and the use thereof

Peptide inhibiting rankl-rank interaction and the use thereof

机译:肽抑制rank-rank相互作用及其用途

摘要

Provided are a peptide for inhibiting an interaction between an RANKL and an RANK consisting of an amino acid sequence of SEQ ID NO: 1 and a pharmaceutical composition for preventing or treating bone diseases including the peptide. The peptide consisting of an amino acid sequence of SEQ ID NO: 1 is not present in a cyclic shape, and has 10 or less amino acids, thereby having better biostability than a conventional peptide to inhibit an RANKL-RANK interaction, being preferable in price during synthesis, and having a better RANKL-RANK interaction inhibitory effect. For this reason, the peptide may be used as an effective component of the composition effectively inhibiting differentiation of osteoclasts. A pharmaceutical composition including the peptide is bound with the RANKL and the peptide, instead of the RANK, thereby inhibiting the interaction between the RANKL and the RANK, and thus inhibiting osteoclast differentiation.
机译:提供了一种用于抑制RANKL和由SEQ ID NO:1的氨基酸序列组成的RANK之间的相互作用的肽,以及用于预防或治疗骨疾病的药物组合物,包括该肽。由SEQ ID NO:1的氨基酸序列组成的肽不呈环状存在,并且具有10个或更少的氨基酸,因此比常规的抑制RANKL-RANK相互作用的肽具有更好的生物稳定性,在价格上是优选的在合成过程中具有更好的RANKL-RANK相互作用抑制作用。因此,可以将该肽用作有效抑制破骨细胞分化的组合物的有效成分。包含所述肽的药物组合物与所述RANKL和所述肽而不是所述RANK结合,从而抑制所述RANKL和所述RANK之间的相互作用,并因此抑制破骨细胞分化。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号